Short answer
Axsome Therapeutics, Inc. (AXSM) filed an 8-K current report with the SEC on February 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 earnings released Feb 23, 2026; details in Exhibit 99.1 press release.
Axsome Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released Feb 23, 2026; details in Exhibit 99.1 press release
- Results cover fiscal year ended Dec 31, 2025: key figures, guidance, and operational updates in the exhibit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Axsome Therapeutics, Inc. 8-K filings
Get the next AXSM 8-K as it lands
Follow AXSM for push alerts, or ask the research agent what this filing means.